The problem with trading Amare is that it wouldn't be done for the typical reasons. Essentially, trading Amare Stoudemire this offseason is like trading uncertainty. This offseason will be the first one in two years that he'll actually be able to work on his skills. Last offseason, he probably was able to improve his jumper a little bit, but most of his time was spent strengthening both of his knees. We know that Amare improved significantly in each offseason before his knee problems, and we should see that again this offseason as well. Whenever you talk about Amare Stoudemire as a basketball player, you have to admit that the guy has a drive to improve. He came into the league wanting to be the best basketball player ever, and I really thought he was on track to do so. If he gets a little more of his athleticism back and refines his post game he could be truly dominate with or without Steve Nash in the game.
All of that said, none of it may ever happen. He's not your typical guy with potential that some GM's are willing to roll the dice on while others are not. There's no way of estimating the probability of him reinjuring his left knee. People say it'll be 5 years and he'll need another microfracture. What does that even mean? If he needs the procedure 5 years from now, what will it be like 3 years from now? Obviously, his knee won't just be perfect for 5 years and wake up one day and not be able to walk. Will it deteriorate gradually or will he just become a bit more susceptible to a serious injury during game action?
Really, it comes down to the fact that there's no in-between here. If Amare is healthy, you would only realistically trade him for an MVP-type guy. Amare for KG? Maybe. Amare for Lebron? Sure. Amare for Kobe? If the situation was right. If he's not healthy, however, he'll be a $15 million contract that's not worth more than a Penny (yes, it's a pun). You can't really trade for, say, Manu Ginobli because he's kind of in between scrub and MVP.